This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

VIVUS Announces Scientific Presentations

MOUNTAIN VIEW, Calif., June 15, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health, today announced the following scientific presentations:

Conference

ENDO 2013: The Endocrine Society's 95 th Annual Meeting and Expo

June 15-18, 2013

Moscone Center, San Francisco, CA

Date/Time

Poster Presentation Date: Saturday, June 15 th, 2013, 1:45-3:45pm

Session Location: Expo Hall, Moscone Center

Poster Number: SAT-663

Abstract Number: 3585

Presentation Title

Improvements in Glycemic Parameters Associated With Magnitude of Weight Loss in Overweight/Obese Subjects Receiving Phentermine and Topiramate Extended-Release Over 2 Years

Authors: Lawrence J. Cheskin, MD a; Charles H. Bowden, MD b

Affiliations: aJohns Hopkins Bloomberg School of Public Health, and Johns Hopkins Weight Management Center, Baltimore, MD bVIVUS, Inc., Mountain View, CA

Conference

ESH 2013: 23 rd European Meeting on Hypertension and Cardiovascular Protection

June 14-17, 2013

Mico Milano Congressi, Milan, Italy

Date/Time

Oral Presentation Date:  Monday, June 17 th, 2013, 9:20-9:30

Session Location:  Red Hall, Mico Milano Congressi

Presentation Title

Improvements in Cardiometabolic Parameters as a Function of Magnitude of Weight Loss in Subjects With Hypertension Treated With Phentermine and Topiramate Extended-Release (PHEN/TPM ER)

Authors: Samuel Klein, MD a; Hermann Toplak, MD b; Roman V. Dvorak, MD, PhD c

Affiliations: aWashington University Medical School, St. Louis, MO, USA bMedical University of Graz, Graz, Austria cVIVUS, Inc., Mountain View, CA, USA

Conference

ESH 2013: 23 rd European Meeting on Hypertension and Cardiovascular Protection

June 14-17, 2013

Mico Milano Congressi, Milan, Italy

Date/Time

Oral Presentation Date:  Monday, June 17 th, 2013, 17:50-18:00

Session Location: Blue Hall , Mico Milano Congressi

Presentation Title

Changes in Hypertension Status Associated With Phentermine and Topiramate Extended-Release Over 108 Weeks

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs